BioTime Company
BioTime is leading the next revolution in medicine – regenerative medicine. Regenerative medicine utilizes advances in stem cell biology, biomaterials, lab-generated cells and tissues, and biologics to engineer and provide healthy cells, tissues and organs to patients with chronic degenerative diseases. This revolution in medical science changes the focus from treating the symptoms of chronic and degenerative diseases to providing actual cures.
Founded Date:
1990-01-01
Investor Type:
N/A
Employee Number:
1-10
Investment Stage:
N/A
Funding Status:
IPO
Number Of Exists:
1
Technology:
Regenerative medicine - cell therapy
Industry:
BioTech
Headquarters:
Boston, Massachusetts, United States
Estimated Revenue:
$1M to $10M